- Home
- ALLR vs CHNR Comparison
ALLR vs CHNR Comparison
Compare ALLR & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- CHNR
- Stock Information
- Founded
- ALLR 2004
- CHNR N/A
- Country
- ALLR United States
- CHNR Hong Kong
- Employees
- ALLR N/A
- CHNR N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- ALLR Health Care
- CHNR Basic Materials
- Exchange
- ALLR Nasdaq
- CHNR Nasdaq
- Market Cap
- ALLR 4.0M
- CHNR 4.8M
- IPO Year
- ALLR N/A
- CHNR 1995
- Fundamental
- Price
- ALLR $1.07
- CHNR $0.57
- Analyst Decision
- ALLR
- CHNR
- Analyst Count
- ALLR 0
- CHNR 0
- Target Price
- ALLR N/A
- CHNR N/A
- AVG Volume (30 Days)
- ALLR 1.4M
- CHNR 13.5K
- Earning Date
- ALLR 05-13-2025
- CHNR 01-01-0001
- Dividend Yield
- ALLR N/A
- CHNR N/A
- EPS Growth
- ALLR N/A
- CHNR N/A
- EPS
- ALLR N/A
- CHNR N/A
- Revenue
- ALLR N/A
- CHNR N/A
- Revenue This Year
- ALLR N/A
- CHNR N/A
- Revenue Next Year
- ALLR N/A
- CHNR N/A
- P/E Ratio
- ALLR N/A
- CHNR N/A
- Revenue Growth
- ALLR N/A
- CHNR N/A
- 52 Week Low
- ALLR $0.61
- CHNR $0.45
- 52 Week High
- ALLR $103.80
- CHNR $1.14
- Technical
- Relative Strength Index (RSI)
- ALLR 60.94
- CHNR 55.22
- Support Level
- ALLR $0.66
- CHNR $0.45
- Resistance Level
- ALLR $1.06
- CHNR $0.55
- Average True Range (ATR)
- ALLR 0.11
- CHNR 0.05
- MACD
- ALLR 0.04
- CHNR 0.01
- Stochastic Oscillator
- ALLR 88.37
- CHNR 78.20
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.